The IDEA (International Duration Evaluation of Adjuvant Chemotherapy) Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy with the FOLFOX (FOLFOX4 or Modified FOLFOX6) or XELOX (3 versus 6 months) Regimen for Patients with Stage III Colon Cancer: Trial Design and Current Status

The International Duration Evaluation of Adjuvant Chemotherapy (IDEA) collaboration was established to prospectively combine and analyze data from several randomized trials conducted around the world to answer whether a three-month course of oxaliplatin-based adjuvant therapy (FOLFOX4/modified FOLFO...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: André, Thierry, Iveson, Timothy, Labianca, Roberto, Meyerhardt, Jeffrey A., Souglakos, Ioannis, Yoshino, Takayuki, Paul, James, Sobrero, Alberto, Taieb, Julien, Shields, Anthony F., Ohtsu, Atsushi, Grothey, Axel, Sargent, Daniel J.
Format: Artigo
Idioma:Inglês
Publicat: Springer US 2013
Matèries:
Adjuvant Therapy for Colon Cancers (AB Benson III and A de Gramont, Section Editors)
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3766516/
https://ncbi.nlm.nih.gov/pubmed/24032000
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11888-013-0181-6
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars